Table 2.

Median VEGF concentration 72 h post-radiation normalized to cell viability (pg/mL) * indicates significant change from control (p < 0.05)

	Abrams	Dharma	D17
Control	0.57	4.76	0.76
Erlotinib	1.22*	7.66	0.75
2Gy	0.37	5.22	0.61
8Gy	0.44	5.67	0.49*
2Gy + Erlotinib	1.32*	9.96	0.56
8Gy + Erlotinib	1.14*	9.32*	0.38*